The START Center for Cancer Research - Logo

Lauren Panco

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

Leave a Comment / Newsroom /

Major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials The START Center for Cancer Research (“START”), the world’s largest early-phase community-based oncology site network, today announced the dosing of the first U.S. participant in Moderna’s Phase 1 study evaluating mRNA-4106, a novel Pan-Tumor Antigen Therapy candidate, in […]

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors Read More »

CURC

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

Leave a Comment / Newsroom /

START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials The START Center for Cancer Research (“START”), a global leader in early-phase oncology clinical trials, announces the expansion of its network with the acquisition of Carolina Urologic Research Center (“CURC”) the premier urologic clinical research site specializing in genitourinary (GU) oncology. This acquisition strengthens

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center Read More »

Thomas' Patient Story

Together in the Fight Against Cancer: Thomas’ Story of Community and Care

Blog /

“I was thinking about this the other night, one of the things that changed was I stopped flossing, because I figured, what’s the point?” Thomas recalls, sitting in a treatment room at START Mountain Region, reflecting on how his perspective had changed after getting his cancer diagnosis. Thomas, who works full-time as a bartender in

Together in the Fight Against Cancer: Thomas’ Story of Community and Care Read More »

Malignant Hematology Blog Banner

Breaking Barriers in Blood Cancer Treatment: Insights on the Future of Malignant Hematology

Blog /

A recent START webinar titled Malignant Hematology: Advancing Treatment in Blood Cancers, provided an in-depth look into the current advancements and challenges in treating hematological malignancies. Moderated by Dr. Andrew Sochacki, Associate Director for Hematology and Clinical Research at START Midwest, the session brought together leading experts to discuss myeloid malignancies, lymphoid malignancies, plasma cell

Breaking Barriers in Blood Cancer Treatment: Insights on the Future of Malignant Hematology Read More »

Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin.

Contact Us
Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.

Who We Serve

Services

About

Resources

START Locations

Patients & Family

Find a Trial
The START Center for Cancer Research - Logo

© 2025 START Research. All rights reserved.

Facebook Linkedin X-twitter